Sartorius | SRT3 - Net Income


Sartorius reported EUR66.1M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Avita Medical AUD -7.66M 3.96M Jun/2026
Dianthus Therapeutics USD -50.22M 9.38M Jun/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
IQVIA Holdings USD 350M 94M Sep/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 108M 38M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Sartorius EUR 66.1M 200K Sep/2026
Tectonic Therapeutic USD -22.28M 2.96M Jun/2026
Viatris USD -118.8M 295.2M Jun/2026
Xeris Pharmaceuticals USD -31.1M 33.34M Jun/2026